Stay updated on TAK-659 in AML Clinical Trial
Sign up to get notified when there's something new on the TAK-659 in AML Clinical Trial page.

Latest updates to the TAK-659 in AML Clinical Trial page
- Check2 days agoChange DetectedShow glossary toggle added; QC labels adjusted (Last Update Submitted that Met QC Criteria) and No FEAR Act data wording updated; footer revision indicator updated from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision history was updated with a new entry Revision: v3.3.4 and the prior Revision: v3.3.3 was removed, indicating a minor log update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedA single 'Locations' section lists all study sites (Alabama, Illinois, Maryland, Massachusetts, Michigan, Minnesota, New York, North Carolina, Ohio, Texas, Wisconsin, Nova Scotia, Ontario) under one heading, replacing the prior separate location entries. The revision label updated to v3.3.3.SummaryDifference1%

- Check66 days agoChange DetectedThe Publications note now states that PubMed auto-fills publications and may not be about the study, and the Revision tag has been updated to v3.3.2.SummaryDifference0.1%

- Check73 days agoChange DetectedRemoved the site-wide notice about government funding delays and NIH operating status; the banner confirming potential delays is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check88 days agoChange DetectedNo significant changes were observed on the page; the study details, eligibility criteria, and locations sections appear unchanged.SummaryDifference0.4%

Stay in the know with updates to TAK-659 in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAK-659 in AML Clinical Trial page.